An HIV-infected Pregnant Woman Treated with the Long-term Administration of Antiretroviral Therapy Including Raltegravir. 2016

Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
Department of Infection Control and Prevention, Kurume University School of Medicine, Japan.

A 27-year-old HIV-infected pregnant Japanese woman was admitted to our hospital at gestational week 14. The patient's HIV viral load was 71,000 copies/mL, and her CD4 cell count was 147 cells/mm(3). Zidovudine, lamivudine, and lopinavir/ritonavir were administered at gestational week 18. Because the viral load increased to 222,000 copies/mL at the initiation of antiretroviral therapy, we added raltegravir. The decrease in the viral load was satisfactory, and a caesarean delivery was performed. Although the plasma concentration of raltegravir in the neonate was significantly high (2,482 ng/mL), no adverse event was confirmed. There was no evidence of the mother-to-child transmission of HIV.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068898 Raltegravir Potassium A pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION. Isentress,MK 0518,MK-0518,MK0518,Raltegravir,0518, MK,Potassium, Raltegravir
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
April 2003, AIDS (London, England),
Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
October 2016, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
April 2013, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
July 1999, AIDS (London, England),
Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
April 2014, The Israel Medical Association journal : IMAJ,
Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
January 2004, Mathematical biosciences,
Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
February 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
May 2017, Infectious disease reports,
Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
February 2016, Bioscience trends,
Kenichiro Yaita, and Shigeru Inoue, and Takashi Horinouchi, and Masahiro Kinoshita, and Mitsuaki Unno, and Osuke Iwata, and Yuhei Tanaka, and Kenji Gotoh, and Mikio Ishibashi, and Yoshiro Sakai, and Kenji Masunaga, and Hiroshi Watanabe, and Masaki Tominaga
June 2006, The Journal of infectious diseases,
Copied contents to your clipboard!